A phase 2b, randomized, double-blind, placebo-controlled, global study to evaluate the efficacy and safety of ANB032 in the treatment of moderate-to-severe atopic dermatitis

被引：0
|
作者：
Ehst, B. [1 ]
Silverberg, J. [2 ]
Lizzul, P. [3 ]
Luu, K. [3 ]
Papacharalambous, J. [3 ]
Raina, P. [3 ]
Randazzo, B. [3 ]
Sibley, C. [3 ]
Guttman-Yassky, E. [4 ]
机构：
[1] Oregon Med Res Ctr, Portland, OR USA
[2] George Washington Univ, Sch Med & Hlth Sci, Washington, DC USA
[3] AnaptysBio, San Diego, CA USA
[4] Icahn Sch Med Mt Sinai, New York, NY USA
来源：
JOURNAL OF INVESTIGATIVE DERMATOLOGY | 2023年 / 143卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
89
引用
收藏
页码：S347 / S347
页数：1
相关论文
共 50 条
  • [31] Sarilumab for the Treatment of Moderate-to-Severe Rheumatoid Arthritis: Results of a Phase 2, Randomized, Double-Blind, Placebo-Controlled, International Study
    Genovese, Mark C.
    Kivitz, Alan J.
    Simon Campos, J. Abraham
    Rell-Bakalarska, Maria
    Fleischmann, Roy M.
    Jasson, Martine
    Radin, Allen R.
    Huang, Xiaohong
    Huizinga, Tom W. J.
    [J]. ARTHRITIS AND RHEUMATISM, 2011, 63 (12): : 4041 - 4042
  • [32] The effect of dupilumab on vaccine antibody responses in adults with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial
    Blauvelt, A.
    Simpson, E.
    Wu, R.
    Akinlade, B.
    Graham, N.
    Pirozzi, G.
    Evans, R.
    [J]. ALLERGY, 2016, 71 : 95 - 95
  • [33] A multicenter, double-blind, randomized, placebo-controlled, phase IIb dose-finding study to evaluate efficacy and safety of spesolimab in patients with moderate-to-severe palmoplantar pustulosis
    Burden, A. David
    Bissonnette, Robert
    Navarini, Alexander A.
    Murakami, Masamoto
    Morita, Akimichi
    Mozzicato, Susan
    Ye, Binqi
    Baehner, Frank
    Terui, Tadashi
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2022, 87 (03) : AB131 - AB131
  • [34] Randomized, placebo-controlled, double-blind study of oral tranexamic acid in the treatment of moderate-to-severe melasma
    Del Rosario, Eunice
    Florez-Pollack, Stephanie
    Zapata, Lucio, Jr.
    Hernandez, Katia
    Tovar-Garza, Andrea
    Rodrigues, Michelle
    Hynan, Linda S.
    Pandya, Amit G.
    [J]. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 78 (02) : 363 - 369
  • [35] EFFICACY AND SAFETY OF ABRILUMAB IN SUBJECTS WITH MODERATE TO SEVERE ULCERATIVE COLITIS: RESULTS OF A PHASE 2B, RANDOMIZED, DOUBLE-BLIND, MULTIPLE-DOSE, PLACEBO-CONTROLLED STUDY
    Sandborn, William J.
    Cyrille, Marcoli
    Hansen, Mark Berner
    Feagan, Brian G.
    Loftus, Edward V.
    Rogler, Gerhard
    Vermeire, Severine
    Cruz, Martha L.
    Yang, Jun
    Sullivan, Barbara A.
    Reinisch, Walter
    [J]. GASTROENTEROLOGY, 2017, 152 (05) : S198 - S198
  • [36] A Phase 2A, randomised, double-blind, placebo-controlled study to evaluate efficacy and safety of PF-06700841 in patients with moderate-to-severe plaque psoriasis
    Forman, S.
    Pariser, D. M.
    Poulin, Y.
    Vincent, M. S.
    Gilbert, S. A.
    Kieras, E. M.
    Qiu, R.
    Yu, D.
    Papacharalambous, J.
    Peeva, E.
    [J]. EXPERIMENTAL DERMATOLOGY, 2018, 27 : 37 - 37
  • [37] Double-blind placebo controlled randomized comparative study of effectiveness and safety of Lactofiltrum for atopic dermatitis in moderate and severe exacerbations
    Zakirova, S.
    [J]. ALLERGY, 2015, 70 : 408 - 408
  • [38] Results of a Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a Botulinum Toxin Type A Topical Gel for the Treatment of Moderate-to-Severe Lateral Canthal Lines
    Glogau, Richard
    Blitzer, Andrew
    Brandt, Fredric
    Kane, Michael
    Monheit, Gary D.
    Waugh, Jacob M.
    [J]. JOURNAL OF DRUGS IN DERMATOLOGY, 2012, 11 (01) : 38 - 45
  • [39] Tralokinumab with topical corticosteroids (TCS) improves health-related quality of life (HRQoL) in adults with moderate-to-severe atopic dermatitis (AD): A Phase 2b, randomized, double-blind, placebo-controlled study
    Silverberg, J. I.
    Kragh, N.
    Guttman-Yassky, E.
    Wollenberg, A.
    [J]. EXPERIMENTAL DERMATOLOGY, 2018, 27 : 41 - 42
  • [40] A Phase 2/3, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Rimegepant for the Preventive Treatment of Migraine
    Croop, R.
    Lipton, R. B.
    Kudrow, D.
    Stock, D. A.
    Kamen, L.
    Conway, C. M.
    Stock, E. G.
    Coric, V.
    Goadsby, P. J.
    [J]. CEPHALALGIA, 2021, 41 (1_SUPPL) : 28 - 29
12345